Funded by the NIH HEAL Initiative®
This cluster-randomized clinical trial with two phases will test expanded treatment access to improve retention on medication treatment for opioid use disorder (MOUD) in highly impacted rural areas. Phase 1 will include implementing telemedicine in a limited number of rural sites with varying levels of OBOT to inform implementation strategies for the main trial and Phase II will include evaluate comparative effectiveness between office-base opioid treatment (OBOT) vs OBOT + telemedicine (TM) in 30 sites.
Yih-Ing Hser, Ph.D.
11075 Santa Monica Boulevard
Los Angeles, CA 90025